Department of Medicine 4 – Nephrology and Hypertension

Chemokine/Cytokine Levels Correlate with Organ Involvement in PR3-ANCA-Associated Vasculitis (2021) Müller-Deile J, Jaremenko C, Haller H, Schiffer M, Haubitz M, Christiansen S, Falk C, Schiffer L Journal article Deletion of Cdh16 Ksp-cadherin leads to a developmental delay in the ability to maximally concentrate urine in mouse (2021) Thomson RB, Dynia DW, Burlein S, Thomson BR, Booth CJ, Knauf F, Wang T, Aronson PS Journal article Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis (2021) Mann J, Buse JB, Idorn T, Leiter LA, Pratley RE, Rasmussen S, Vilsboll T, et al. Journal article Role of Microparticles in Cardiovascular Disease Implications for Endothelial Dysfunction, Thrombosis, and Inflammation (2021) Lugo-Gavidia LM, Burger D, Matthews VB, Nolde JM, Galindo Kiuchi M, Carnagarin R, Kannenkeril D, et al. Journal article, Review article Prevalence of mental disorders in a German kidney transplant population - results of a KTx360 degrees-substudy (2021) Noehre M, Birkefeld K, Bauer-Hohmann M, Tun EMKT, Tegtbur U, Pape L, Schiffer L, et al. Conference contribution AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects? (2021) Rodionova K, Hindermann M, Hilgers KF, Ott C, Schmieder R, Schiffer M, Amann KU, et al. Journal article, Original article Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients (2021) Braunisch MC, Gundel P, Werfel S, Mayer CC, Bauer A, Haller B, Guenthner R, et al. Journal article Visualization of the epimysium and fascia thoracolumbalis at the lumbar spine using MRI (2021) Adamietz B, Schoenberg SO, Reiser M, Uder M, Frank A, Strecker R, Weiss C, Heiß R Journal article THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, et al. Conference contribution